Ying En Biology (09606) has filed for an IPO on the Shanghai Stock Exchange Science and Technology Innovation Board, specializing in the field of antibody drug conjugates (ADCs).

According to the Zhitong Financial APP, on June 12th, Duality Biotherapeutics Inc (referred to as: Duality Biotherapeutics) has submitted its application for an IPO on the Shanghai Stock Exchange's Sci-Tech Innovation Board. CITIC Securities is its sponsor institution, with plans to raise 4.1 billion yuan.